Abstracts - faqs.org

Abstracts

Law

Search abstracts:
Abstracts » Law

The learned intermediary doctrine and direct-to-consumer advertising of prescription drugs

Article Abstract:

The authors discuss the learned intermediary doctrine defense, which proved that makers for prescription drugs and medical devices fulfill their duty of care to patients by providing warnings to the prescribing physicians. Topics include the treatment of the doctrine in the Third Restatement of Torts and FDA guidelines on direct broadcast advertising to consumers.

Author: Pratt, Timothy A., Kuckelman, John F.
Publisher: Federation of Defense and Corporate Counsel
Publication Name: Federation of Insurance & Corporate Counsel Quarterly
Subject: Law
ISSN: 0887-0942
Year: 2000
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Drugs, Pharmaceutical industry, Advertising, Medical malpractice, Failure to warn (Law), Pharmacists

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Parent corporation liability under CERCLA

Article Abstract:

The author discusses the U.S. Supreme Court 1998 case United States v. Best Foods where the court addresses the conflict in the circuit courts concerning the liability of parent corporations for environmental damages caused by subsidiary corporations under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA).

Author: Hilbert, Catherine Ann
Publisher: Widener University School of Law
Publication Name: Delaware Journal of Corporate Law
Subject: Law
ISSN: 0364-9490
Year: 1999
Cases, Affiliated corporations, Corporations, Tort liability, Case Note, Toxic torts, Tort liability of corporations

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The Biomaterials Access Assurance Act of 1998 and corporate supplier liability: Who you gonna sue?

Article Abstract:

The author provides an overview of the Biomaterials Access Assurance Act of 1998 and discusses the common law doctrine that protects suppliers of component parts for medical devices from products liability lawsuits and FDA regulation. Suits over implants used to treat temporomandibular joint syndrome are also discussed.

Author: Murphy, Ann Marie
Publisher: Widener University School of Law
Publication Name: Delaware Journal of Corporate Law
Subject: Law
ISSN: 0364-9490
Year: 2000
Care and treatment, Temporomandibular joint disorders, Biomedical materials, Biomaterials

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Laws, regulations and rules, Medical equipment, Medical equipment and supplies industry, Medical equipment industry
Similar abstracts:
  • Abstracts: The next terminator. Humming in perfect time. A season of change
  • Abstracts: Leveraged leasing: perfecting a security interest in an owner trust. Mexico's secured lending reforms
  • Abstracts: The Nile River: potential for conflict and cooperation in the face of water degradation. Institutions and conjunctive water management among three Western states
  • Abstracts: Trapped income of a RIC. Sale of subsidiary did not constitute a change in ownership or control for purposes of the golden parachute rules under Section 280G
  • Abstracts: The cross-border insolvency paradigm: a defense of the modified universal approach considering the Japanese experience
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.